R&D Systems™ Recombinant Human IL-1 RAcP/IL-1 R3 Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IL-1 RAcP/IL-1 R3 Protein is derived from HEK293. The Recombinant Human IL-1 RAcP/IL-1 R3 Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

Specifications

• Accession Number: Q9NPH3
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS.
• Gene ID (Entrez): 3556
• Molecular Weight (g/mol): 40 kDa
• Name: C3orf13IL-1RAcPIL1R3Interleukin-1 receptor 3, FLJ37788, IL-1 R3, IL-1 receptor accessory protein, IL-1R3, IL-1R-3, IL1RAcP, IL-1RAcP, IL1RAP, interleukin 1 receptor accessory protein, interleukin-1 receptor accessory protein, interleukin-1 receptor access
• Quantity: 100μg
• Source: Human embryonic kidney cell,HEK293-derived human IL-1 RAcP/IL-1 R3 protein Ser21-Glu359,with a C-terminal 6-His tag
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1μg of protein by LAL method
• Biological Activity: Measured by its ability to inhibit IL-1 alpha -induced IL-8 secretion in HepG2 human hepatocellular carcinoma cells. The ED50 for this effect is 0.8‑4 μg/mL in the presence of 1 μg/mL of recombinant human (rh) IL-1 R2 Fc Chimera and 50 pg/mL rhIL-1 alp
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Purity or Quality Grade: >90%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

For Research Use Only